Monitoring and managing nighttime high blood pressure
Registry Study on "Control Nocturnal Hypertension to Reach the Target "（CONTROL-NHT）
This study is testing how monitoring nighttime blood pressure can help people aged 50-79 with high blood pressure manage their condition better and reduce their risk of heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4500 (estimated) |
| Ages | 50 Years to 79 Years |
| Sex | All |
| Sponsor | Shanghai Institute of Hypertension Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT04137549 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients aged 50-79 with diagnosed hypertension who are using antihypertensive medications. It aims to monitor nocturnal blood pressure using ambulatory blood pressure monitoring (ABPM) to identify and manage nocturnal hypertension, which is linked to increased cardiovascular risks. The study emphasizes the importance of controlling blood pressure during nighttime to potentially reduce the risk of serious cardiovascular events. Participants will provide information about their medical history and undergo blood biochemical tests.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50-79 with diagnosed hypertension who are currently taking antihypertensive medications and have elevated nocturnal blood pressure.
Not a fit: Patients who do not use antihypertensive drugs or those who are hospitalized for hypertension may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of nocturnal hypertension, reducing the risk of cardiovascular events in patients.
How similar studies have performed: Other studies have shown that monitoring nocturnal blood pressure can provide valuable insights into cardiovascular risk, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 50-79 years old * Clinical diagnosed hypertension with the use of antihypertensive drugs * Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg) * A 24-hour ambulatory blood pressure monitoring was performed with validated equipment. * Willing to provide information about disease history and blood biochemical test data within 6 months. * Sign the informed consent Exclusion Criteria: * Without antihypertensive drug use * Hospitalized hypertension patients * Non-compliant patient
Where this trial is running
Shanghai, Shanghai Municipality
- Ruijin Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yan Li, MD,PhD
- Email: liyanshcn@163.com
- Phone: 0086-021-64370045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.